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A novel 2H-azirin-3-amine as a synthon for a sulfur-
containing dipeptide segment 
 
Svetlana A. Stoykova, Anthony Linden, and Heinz Heimgartner* 
 
Institute of Organic Chemistry, University of Zürich, Winterthurerstrasse 190, CH-
8057 Zürich, Switzerland 
 
 
Starting with tetrahydro-2H-thiopyran-4-carboxylic acid and methyl 
prolinate, the novel 2H-azirin-3-amine (S)-N-(1-aza-6-
thiaspiro[2.5]oct-1-en-2-yl)proline methyl ester was synthesized. In 
reactions with benzoic acid, thiobenzoic acid, and Boc-valine, 
respectively, its usefulness as a synthon for the dipeptide (S)-N-[(4-
aminotetrahydro-2H-thiopyran-4-yl)carbonyl]proline in peptide 
synthesis was demonstrated. 
 
Keywords: 2H-azirin-3-amines; N-(1-aza-6-thiaspiro[2.5]oct-1-en-2-
yl)proline methyl ester; α-amino acids; 4-aminotetrahydro-2H-
thiopyran-4-carboxylic acid; sulfur-heterocyclic amino acids 
 
 
1. Introduction 
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In the past we have shown that 2,2-disubstituted 2H-azirin-3-amines 1 are building 
blocks for 2,2-disubstituted α-amino acids in the synthesis of heterocycles as well as 
of peptides [1–3]. The smooth coupling reaction with N-protected amino acids or 
peptides 2 to give extended peptide amides 3 does not need any additional reagent, 
and the subsequent hydrolysis of the terminal amide group leading to peptides 4 
occurs selectively (Scheme 1). This method has been used successfully towards the 
synthesis of natural peptaibol antibiotics [4–10]. 
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Scheme 1. Reaction of 2H-azirin-3-amines with amino acids and selective hydrolysis; 
the ‘azirine/oxazolone method’ 
 
Spiroheterocyclic 2H-azirines of type 1b, which serve as synthons for heterocyclic 
α-amino carboxylic acids, form a special class of these synthons [11–15]. For 
example, the tetrahydro-2H-thiopyran derivative 1b (X = S, n = 1) has been used to 
prepare tripeptides containing 4-aminotetrahydro-2H-thiopyran-4-carboxylic acid (5) 
[12]. This heterocyclic amino acid has been described as a cyclic homocysteine [16] 
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or methionine analog [17], and was prepared via Strecker synthesis [18], the 
Bucherer-Bergs reaction [17,19], or the Ugi reaction [20]. The crystal structure of 5 
has been published in 1976 [21]. The interest in the amino acid 5 is based on the 
biological activities of some of its derivatives, e.g., as inhibitors of S-adenosyl L-
methionine synthetase [19], glycogen phosphorylase inhibitor [22], or ecdysone 
agonist [23]. 
Heterocyclic amino acids of type 5 have also been used in the synthesis of 
conformationally restricted peptides [24]. Like other α,α-disubstituted α-amino acids, 
the presence of 5 forces peptides to form β-turns [12] or helical conformations. In our 
studies towards the synthesis of such sterically congested oligopeptides with a helical 
conformation by using the ‘azirine/oxazolone method’ [25–29], we introduced N-(2,2-
dimethyl-2H-azirin-3-yl)proline methyl ester as a dipeptide (Aib-Pro) synthon [30–
32] as well as other dipeptide (Xaa-Pro) synthons, including those with Xaa being a 
heterocyclic α-amino acid [13,33,34]. The aim of the present study was the synthesis 
of (S)-N-(1-aza-6-thiaspiro[2.5]oct-1-en-2-yl)proline methyl ester (1c) and its use as a 
(S)-N-[(4-aminotetrahydro-2H-thiopyran-2-yl)carbonyl]proline (Tht-Pro) synthon. 
 
2. Results and discussion 
 
2.1. Synthesis of the Heterospirocyclic Azirine 1c. As the method of Villalgordo for 
the synthesis of 2H-azirin-3-amines 1 [35], used by Strässler for the preparation of 1b 
(n = 1) [12], is limited to N-alkyl-N-phenyl derivatives, we decided to prepare N-
[(tetrahydro-2H-thiopyran-4-yl)thiocarbonyl]-L-proline methyl ester (9), with the aim 
of following the protocol of the aminoazirine synthesis published by Rens and Ghosez 
[36] and modified by Dietliker [37]. Thus, tetrahydro-2H-thiopyran-4-carboxylic acid 
 4 
chloride (6) [12] was reacted with L-proline methyl ester (7) to give N-[(tetrahydro-
2H-thiopyran-4-yl)carbonyl]-L-proline methyl ester (8) in 85% yield, which was 
converted to 9 by thionation with Lawesson reagent in 67% yield (Scheme 2). In 
analogy to the procedure described in [30] and to the protocol for the synthesis of 1b 
(X = O, n = 1) [34], consecutive treatment of a solution of 9 in CH2Cl2 and catalytic 
amounts of DMF with COCl2, evaporation of the solvent, dissolution of the residue in 
THF, addition of 1,4-diazabicyclo[2.2.2]octane (DABCO), filtration, and reaction 
with NaN3 gave azirine 1c in 67% yield. Because of the decomposition of the crude 
product during its purification using column chromatography (SiO2), the compound 
was used in the next reactions without further purification. 
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Scheme 2. Synthesis of the dipeptide (Tht) synthon 1c 
 
2.2. Reactions of 1c with Carboxylic and Thiocarboxylic Acids. For the chemical 
characterization of 1c, reactions with thiobenzoic acid (PhCOSH) and 4-
bromobenzoic acid (p-BrBz-OH) were performed in THF at 0 °C to room temperature 
[34] (for reactions of 1c with H2O and H2S, see [38]). After chromatographic workup 
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of the mixture of the reaction with p-BrBz-OH, the p-bromobenzoyl-dipeptide methyl 
ester 10 was isolated in 45% yield. Similarly, after successful chromatography, the N-
benzoylated endothiopeptide methyl ester 11 was obtained in 85% yield (Scheme 3).  
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Scheme 3. Reactions of 1c with carboxylic, thiocarboxylic, and amino acids 
 
With the aim of testing the utility of 1c as a dipeptide synthon (Tht-Pro) in peptide 
synthesis, the reaction with Boc-protected L-valine (Boc-Val-OH) was carried out in 
THF. A solution of Boc-Val-OH (1 mol-equiv.) in THF was cooled to 0 °C. Then, 1c 
(2 mol-equiv.) was added at 0 °C, and the mixture was stirred for 43 hours at room 
temperature. After chromatographic purification of the product, the N-protected 
tripeptide methyl ester Boc-Val-Tht-Pro-OMe (12) was obtained in 44% yield as a 
white foam (Scheme 3). Suitable single-crystals of 12 could be obtained from 
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CHCl3/hexane by slow evaporation of the solvent, and its structure was established by 
an X-ray crystal-structure analysis (Figure 1). 
 
 
 
Figure 1. ORTEP plot [39] of the molecular structure of 12 (with 50% probability 
ellipsoids; arbitrary numbering of atoms) 
 
Although there is no intramolecular H-bond present, the peptide backbone of 12 
adopts a conformation resembling β-turns of Aib-containing oligopeptides. The 
torsion angles φ (C(6)-C(5)-N(4)-C(3)) and ψ (N(4)-C(5)-C(6)-N(7)) of the 
tetrahydro-2H-thiopyran-4-yl (Tht) residue are 53.1(2) and 38.9(2)°, respectively. 
They are close to the values expected for an amino acid in a β-turn of type I or III. 
Each N-H group of the molecule acts as a donor for intermolecular H-bonds: N(1)-H 
forms an intermolecular H-bond with the ester carbonyl O-atom at the opposite end of 
a neighboring molecule (N(1)···O(9’): 2.955(2) Å, angle 170(2)°). This interaction 
links the molecules into extended one-dimensional chains which run parallel to the 
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[010] direction and have a graph set motif [40] of C(11). N(4)-H interacts with the 
secondary amide O-atom of a different neighboring molecule (N(4)···O(6’’): 2.976(2) 
Å, angle 167(2)°), and thereby links the molecules into extended one-dimensional 
chains which run parallel to the [100] direction and have a graph set motif of C(5). 
The combination of both interactions links the molecules into a two-dimensional 
network, which lies parallel to the (001) plane (Figure 2). 
 
 
 
Figure 2. Crystal packing diagram of 12, showing the H-bonding interactions 
(uninvolved H-atoms omitted for clarity). 
 
3. Conclusions 
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The studies presented show that the new spirocyclic N-(2H-azirin-3-yl)proline 
derivative 1c can be prepared according to previously reported protocols. In the 
reactions with PhCOSH, p-BrBz-OH, and N-protected α-amino acids, 1c behaves like 
other 2H-azirin-3-amines (= 3-amino-2H-azirines) that have been used extensively as 
building blocks for α,α-disubstituted glycines in peptide synthesis. The novel amino 
azirine 1c was shown to be a synthon for the dipeptide N-[(4-aminotetrahydro-2H-
thiopyran-4- yl)carbonyl]-L-proline (Tht-Pro). In the crystal, the prepared tripeptide 
Boc-Val-Tht-Pro-OMe (12) adopts a β-turn conformation, despite the lack of the 
typical intramolecuar hydrogen bond. This is a further proof of the intrinsic property 
of α,α-disubstituted α-amino acids to stabilize β-turns or 310-helical structures in 
peptides (see [32] and refs. cited therein). 
 
4. Experimental 
 
4.1. General 
All purchased chemicals were of analytical grade and used without further 
purification; solvents were purified by standard procedures. TLC was performed 
using pre-coated aluminium sheets (Merck silica gel 60F254), and column 
chromatography (CC) on silica gel C-560 (230–400 mesh; Uetikon-Chemie). Melting 
points were determined on a Büchi Melting Point B-450 apparatus and are not 
corrected. IR spectra were recorded on a Perkin-Elmer, Spectrum one FT-IR 
spectrophotometer in KBr (cm-1), 1H (300 or 600 MHz) and 13C NMR spectra (75.6 or 
150 MHz) on a Bruker AC-300 or Bruker DRX-600 spectrometer in CDCl3 (ppm, J in 
Hz), 13C-signal multiplicity from DEPT spectra, and mass spectra on a Finnigan SSQ-
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700 (CI with NH3) or Finnigan TSQ-700 (ESI) instrument, significant peaks in m/z 
(rel. %).  
 
4.2. Synthesis of (S)-N-[(tetrahydro-2H-thiopyran-4-yl)carbonyl]proline methyl 
ester (8).  
To cooled MeOH (8 ml) was slowly added SOCl2 (1.73 ml) keeping the temp. below 
0 °C. Then, (S)-proline (2.53 g, 21.97 mmol) was added, and the mixture was heated 
at reflux for 1 h. Excess MeOH was evaporated, the sticky pale yellow crude methyl 
(S)-prolinate (7) was dissolved in AcOEt (8 ml), Et3N (6.12 ml) and tetrahydro-2H-
thiopyran-4-carbonyl chloride (6, 3.62 g, 21.97 mmol) [12] were added at 0 °C, and 
the mixture was stirred at rt overnight. After evaporation of AcOEt, the residue was 
dissolved in CH2Cl2, the solution was washed with sat. aqueous NaCl solution, dried 
over MgSO4, CH2Cl2 was evaporated, and the residue was distilled (bulb-to-bulb, 190 
°C/5.10–2 mbar): 4.81 g (85%) of 8. Pale yellow oil. IR (film): 2951s, 1744s, 1643s, 
1434s, 1357m, 1303w, 1271m, 1239w, 1197s, 1175s, 1116w, 1096w, 1029w, 1012w, 
934m, 733m. 1H-NMR: 4.49–4.45 (m, CH(α)(Pro)); 3.72 (s, MeO); 3.68–3.65, 3.58–
3.53 (2m, CH2(δ)(Pro)); 2.73–2.71 (m, CH2(2), CH2(6)(Tht)); 2.46–2.42 (m, 
CH(4)(Tht)); 2.20–2.06 (m, 3 H); 2.02–1.89 (m, 5 H). 13C-NMR: 173.5, 172.7 (2s, 2 
C=O); 58.5 (d, CH(α)(Pro)); 52.0 (q, MeO); 46.7 (t, CH2(δ)(Pro)); 42.5 (d, 
C(4)(Tht)); 30.1, 29.8 (2t, C(2), C(6)(Tht)); 29.5 (t, CH2(β)(Pro)); 27.7, 27.6 (2t, C(3), 
C(5)(Tht)); 24.7 (t, CH2(γ)(Pro)). CI-MS: 275 (30, [M + NH4]+), 258 (100, [M + H]+). 
 
4.3. Synthesis of (S)-N-[(tetrahydro-2H-thiopyran-4-yl)thiocarbonyl]-proline methyl 
ester (9).  
To a solution of 8 (3.89 g, 15.1 mmol) in abs. toluene (46 ml) was added Lawesson 
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reagent (7.4 g, 18.3 mmol), and the mixture was stirred at reflux for 4 h and then at r.t. 
overnight. Then, the mixture was filtered (Celite), the solvent evaporated and the 
crude product was purified by gradient chromatography (SiO2, CH2Cl2/MeOH from 
200:1 to 150:1) to give 2.77 g (67%) of 9. Pale yellow oil. 1H-NMR: 5.15 (dd, J = 8.6, 
8.4 CH(α)(Pro)); 3.91–3.85, 3.77–3.75 (2m, CH2(δ)(Pro)); 3.72 (s, MeO); 2.84–2.63 
(m, 5 H); 2.31–2.00 (m, 8 H). 13C-NMR: 206.1 (s, C=S); 170.9 (s, C=O); 64.9 (d, 
CH(α)(Pro)); 52.2 (q, MeO); 50.2 (t, CH2(δ)(Pro)); 49.0 (d, C(4)(Tht)); 33.4, 32.9 (2t, 
C(2), C(6)(Tht)); 28.6, 28.2 (2t, C(3), C(5)(Tht)); 28.0 (t, CH2(β)(Pro)); 24.5 (t, 
CH2(γ)(Pro)). EI-MS: 273 (100, M+), 226 (37), 212 (43). 
 
4.4. Synthesis of methyl (S)-N-(1-aza-6-thiaspiro[2.5]oct-1-en-2-yl)proline methyl 
ester (1c). In a dried two-neck round-bottom flask, a solution of 9 (2.5 g, 9.14 mmol) 
in abs. CH2Cl2 (11 ml) and 3 drops of DMF was cooled to 0 °C. After slow addition of 
5.5 ml of a COCl2 solution in toluene (2M, 11 mmol), the mixture was stirred at rt for 
1 h, and then the solvent was evaporated. The residue was dissolved in THF (22.5 
ml), DABCO (1.23 g, 11 mmol) was added at 0 °C, and the mixture was stirred at rt 
for 40 min. The solid was removed by filtration under Ar and washed with THF. To 
the pale yellow solution was added NaN3 (1.78 g, 27.42 mmol), the mixture was 
stirred at rt overnight, filtered through a Celite pad, and the solvent was evaporated. 
The residue was dissolved in AcOEt, the solution was washed with sat. aqueous 
NaHCO3 and NaCl solution, the organic layer was dried  over MgSO4, and 
evaporated. The crude product 1c was obtained in 67% yield. It could not be purified 
by chromatography because of decomposition, therefore, it was used without further 
purification. 
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4.5. General procedure for reactions of 1c with PhCOSH, p-BrBz-OH, and Boc-
Val-OH.  
To a solution of the acid in dry THF at 0 °C, a solution of ca. 2 mol-equiv. of 1c in 
dry THF was added dropwise. The mixture was stirred at rt. After completion of the 
reaction (TLC), the solvent was evaporated in vacuo and the residue was purified by 
gradient CC (SiO2; CH2Cl2/MeOH). 
 
4.5.1. (S)-N-({4-[(4-Bromobenzoyl)amino]tetrahydro-2H-thiopyran-4- 
yl}carbonyl)proline methyl ester (p-BrBz-Tht-Pro-OMe, 10).  
According to the general procedure, p-BrBz-OH (196 mg, 0.975 mmol) and 1c (496 
mg, 1.950 mmol), stirring for 20 h, and CC (CH2Cl2/MeOH from 150:1 to 40:1) gave 
199.8 mg (45%) of 10. White foam. M.p. 238–239 °C. IR: 3331m, 2951m, 2924m, 
1744s, 1651s, 1617s, 1591m, 1567w, 1530s, 1482s, 1440m, 1407m, 1359m, 1315w, 
1298w, 1279w, 1245w, 1207m, 1174s, 1112w, 1066m, 1040w, 1011m, 760m. 1H-
NMR (CD3OD): 7.78–7.74 (m, 2 arom. H); 7.69–7.64 (m, 2 arom. H); 4.51–4.48 (m, 
CH(α)(Pro)); 3.78–3.75 (m, 1 H); 3.72 (s, MeO); 2.97–2.83 (m, 2 H); 2.76–2.52 (m, 3 
H); 2.41–2.18 (m, 3 H); 2.11–1.82 (m, 5 H). 13C-NMR (CD3OD): 173.3, 171.0 (2s, 2 
C=O); 165.5 (s, ArC=O); 132.3 (s, 1 arom. C); 131.8, 128.7 (2d, 4 arom. CH); 126.6 
(s, 1 arom. C); 60.6 (d, CH(α)(Pro)); 58.6 (s, C(4)(Tht)); 52.0 (q, MeO); 47.6 (t, 
CH2(δ)(Pro)); 33.3, 32.8, 27.4, 25.7, 24.2, 23.1 (6t, 6 CH2). ESI-MS: 479 (100, 
[M(81Br ) + Na]+), 477 (96, [M(79Br) + Na]+). 
 
4.5.2. (S)-N-{[4-(Benzoylamino)tetrahydro-2H-thiopyran-4-yl]thiocarbonyl}proline 
methyl ester (Bz-Tht-Ψ(CS)-Pro-OMe, 11). According to the general procedure, 
PhCOSH (28 mg, 0.203 mmol) and 1c (103.4 mg, 0.407 mmol), stirring for 90 h, and 
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CC (CH2Cl2/MeOH from 150:1 to 110:1) gave 67.7 mg (85%) of 11. White foam. 
M.p. 139–140 °C. IR: 3452m, 2949m, 2924m, 1741s, 1638s, 1601w, 1579m, 1449w, 
1409s, 1348w, 1276m, 1248m, 1203m, 1171s, 1107m, 1057w, 1043w, 1001m, 965m, 
877m, 799m, 716s, 646m. 1H-NMR (CD3OD): 7.59 (d, J = 7.0, 2 arom. H); 7.61–7.48 
(m, 3 arom. H); 5.06 (broad d, J = 6.3, CH(α)(Pro)); 4.06–4.00 (m, 1 H); 3.68 (s, 
MeO); 3.59–3.53 (m, 1 H); 3.21–3.11 (m, 1 H); 2.91–2.80 (m, 3 H); 2.59–2.55 (m, 3 
H); 2.25–1.90 (m, 5 H). 13C-NMR (CD3OD): 206.2 (s, C=S); 173.1 (s, C=O); 168.9 
(s, PhC=O); 135.3 (s, 1 arom. C); 133.1, 129.8, 127.8 (3d, 5 arom. CH); 70.2 (d, 
CH(α)(Pro)); 64.6 (s, C(4)(Tht)); 54.0 (q, MeO); 53.7 (t, CH2(δ)(Pro); 36.8, 36.1, 
28.5, 26.9, 24.9, 24.1 (6t, 6 CH2). CI-MS: 410 (32, [M + NH4]+), 393 (100, [M + H]+), 
361 (78, [M – OMe]+), 272 (17). 
 
4.5.3. (S)-N-{[4-({(2S)-2-[(tert-Butoxycarbonyl)amino]-3-methylbutanoyl}amino)-
tetrahydro-2H-thiopyran-4-yl]carbonyl}proline methyl ester (Boc-Val-Tht-Pro-
OMe, 12).  
According to the general procedure, Boc-Val-OH (126.4 mg, 0.582 mmol) and 1c 
(296 mg, 1.164 mmol), stirring for 43 h, and CC (CH2Cl2/MeOH from 150:1 to 
110:1) gave 120 mg (44%) of 12. White foam. M.p. 225–226 °C. IR: 3370s, 3321s, 
2974m, 1732s, 1711s, 1686s, 1603s, 1528s, 1427m, 1391w, 1361m, 1322w, 1276w, 
1245m, 1220m, 1171s, 1097m, 1068w, 1039w, 985m, 924m, 881m, 609m. 1H-NMR: 
7.24 (s, NH); 5.06 (d, J = 8.9, NH(Val)); 4.58–4.50 (m, CH(α)(Pro)); 3.86–3.83 (m, 
CH(α)(Val)); 3.71 (s, MeO); 3.64–3.62, 3.60–3.51 (2m, CH2(δ)(Pro)); 3.10–2.87 (m, 
1 H); 2.68–2.59 (m, 4 H); 2.20–2.16 (m, CH(β)(Val)); 2.12–1.98 (m, 5 H); 1.89–1.83 
(m, 2 H); 1.46 (s, 9 H, Me3C); 1.00–0.94 (2d, J = 6.8, 2 Me(Val)). 13C-NMR: 173.0, 
170.3, 170.0 (3s, 3 C=O); 155.9 (s, C=O(Boc)); 80.1 (s, Me3C); 60.5 (d, CH(α)(Pro)); 
 13 
60.1 (d, CH(α)(Val)); 58.1 (s, C(4)(Tht)); 51.9 (q, MeO); 47.4 (t, CH2(δ)(Pro)); 33.3, 
33.2 (2t, C(2), C(6)(Tht)); 30.1 (d, CH(β)(Val)); 28.2 (q, Me3C); 27.5 (t, 
CH2(β)(Pro)); 25.9 (t, CH2(γ)(Pro)); 24.2, 23.2 (2t, C(3), C(5)(Tht)); 19.5, 17.9 (2q, 2 
Me(Val)). ESI-MS: 494 (100, [M + Na]+). 
Suitable crystals of 12 for the X-ray crystal-structure determination were grown 
from CHCl3/hexane by slow evaporation of the solvent at rt. 
 
5. X-ray crystal-structure determination of 12  
All measurements were made on a Nonius KappaCCD area-detector diffractometer 
[41] using graphite-monochromated MoKα radiation (λ  0.71073 Å) and an Oxford 
Cryosystems Cryostream 700 cooler. Data reduction was performed with HKL Denzo 
and Scalepack [42]. The intensities were corrected for Lorentz and polarization 
effects, and an absorption correction based on the multi-scan method [43] was 
applied.  Equivalent reflections, other than Friedel pairs, were merged. Data collection 
and refinement parameters are given below [44], and views of the molecule and the 
crystal packing are shown in Figures 1 and 2. The structures were solved by direct 
methods using SIR92 [45], which revealed the positions of all non-H-atoms. The non-
H-atoms were refined anisotropically. The amide H-atoms were placed in the 
positions indicated by a difference electron density map, and their positions were 
allowed to refine together with individual isotropic displacement parameters.  All 
remaining H-atoms were placed in geometrically calculated positions and refined 
using a riding model where each H-atom was assigned a fixed isotropic displacement 
parameter with a value equal to 1.2Ueq of its parent C-atom (1.5Ueq for the methyl 
groups). Refinement of the structure was carried out on F2 using full-matrix least-
squares procedures, which minimized the function Σw(Fo
2-Fc
2)2. A correction for 
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secondary extinction was applied. Refinement of the absolute structure parameter [46] 
yielded a value of –0.01(5), which confidently confirms that the refined coordinates 
represent the true enantiomorph. Neutral atom scattering factors for non-H-atoms 
were taken from ref. [47], and the scattering factors for H-atoms were taken from ref. 
[48]. Anomalous dispersion effects were included in Fc [49]; the values for ƒ’ and ƒ” 
were those of ref. [50]. The values of the mass attenuation coefficients are those of 
ref. [51]. All calculations were performed using the SHELXL97 [52] program. 
Crystal data for 12: C22H37N3O6S, M = 471.61, crystallized from CH3Cl/hexane, 
colorless, tablet, crystal dimensions 0.07 × 0.15 × 0.18 mm, triclinic, space group P1, 
Z = 1, reflections for cell determination 23944, 2θ range for cell determination 4 – 
55°, a = 6.1889(2) Å, b = 10.0211(3) Å, c = 10.8337(4) Å, α = 95.567(1)°, β = 
96.425(1)°, γ = 107.156(1)°, V = 631.96(4) Å3, T = 160(1) K, DX = 1.239 g⋅cm–3, 
µ(MoKα) = 0.168 mm–1, scan type φ and ω, 2θ(max) = 55°, transmission factors (min; 
max) = 0.883; 0.990, total reflections measured 14952, symmetry independent 
reflections 5406, reflections with I > 2σ(I) 4984, reflections used in refinement 5406, 
parameters refined 304, restraints 3; R(F) [I > 2σ(I) reflections] = 0.0335, wR(F2) [all 
data] = 0.0843 (w = [σ2(Fo2) + (0.0367P)2 + 0.0767P]–1, where P = (Fo2 + 2Fc2)/3), 
goodness of fit 1.052, secondary extinction coefficient 0.075(8), final Δmax/σ 0.001, 
Δρ (max; min) = 0.23; –0.20 e Å–3. 
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